The makers of branded pharmaceuticals have devised numerous ways to extend patent exclusivity for lucrative products in the United States. In June, the Supreme Court gave the Federal Trade Commission (FTC) clear authority to investigate and prosecute...
Filed under: All Categories, Consumers, Policy, Insurance, Payment, Health Care Costs, Spending, Medicare, Competition, Pharma, Business of Health Care